Summit Therapeutics,
The Director, Value Outcomes Liaison will engage US population‑based decision makers such as payers, health systems, and policy makers to communicate the clinical, economic, and humanistic value of ivonescimab. The role partners with commercial market access and internal HEOR teams to provide scientific information, support formulary and pathway decisions, and gather stakeholder insights.
Headquarters
Miami, Florida, United States
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Summit Therapeutics,.
5% below the average for this role